|In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes.|
|Jump to Full Text|
|PMID: 22522929 Owner: NLM Status: MEDLINE|
|The reprogramming of adult cells into pluripotent cells or directly into alternative adult cell types holds great promise for regenerative medicine. We reported previously that cardiac fibroblasts,which represent 50%of the cells in the mammalian heart, can be directly reprogrammed to adult cardiomyocyte-like cells in vitro by the addition of Gata4, Mef2c and Tbx5 (GMT). Here we use genetic lineage tracing to show that resident non-myocytes in the murine heart can be reprogrammed into cardiomyocyte-like cells in vivo by local delivery of GMT after coronary ligation. Induced cardiomyocytes became binucleate, assembled sarcomeres and had cardiomyocyte-like gene expression. Analysis of single cells revealed ventricular cardiomyocyte-like action potentials, beating upon electrical stimulation, and evidence of electrical coupling. In vivo delivery of GMT decreased infarct size and modestly attenuated cardiac dysfunction up to 3 months after coronary ligation. Delivery of the pro-angiogenic and fibroblast-activating peptide, thymosin b4, along with GMT, resulted in further improvements in scar area and cardiac function. These findings demonstrate that cardiac fibroblasts can be reprogrammed into cardiomyocyte-like cells in their native environment for potential regenerative purposes.|
|Li Qian; Yu Huang; C Ian Spencer; Amy Foley; Vasanth Vedantham; Lei Liu; Simon J Conway; Ji-dong Fu; Deepak Srivastava|
Related Documents :
|8967339 - Differentiated phenotype of glomerular mesangial cells in nodular culture.
3872889 - Regulation of human b cell activation by prostaglandin e2. suppression of the generatio...
11327079 - Involvement of cyclooxygenase-2 in serum-induced prostaglandin production by human oral...
7617119 - Mitosis and the presence of binucleate cells among glomerular podocytes in diseased hum...
7871629 - Madin-darby canine kidney cells are injured by exposure to oxalate and to calcium oxala...
8396229 - An immunohistochemical study comparing clear cell sarcoma of the kidney and wilms' tumor.
16346189 - Affinity immobilization of escherichia coli: catalysis by intact and permeable cells bo...
7441539 - The discharges during movement of cells in the ventrolateral thalamus of the conscious ...
23654749 - Improving the sound absorbing efficiency of closed-cell foams using shock waves.
|Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't|
|Title: Nature Volume: 485 ISSN: 1476-4687 ISO Abbreviation: Nature Publication Date: 2012 May|
|Created Date: 2012-06-05 Completed Date: 2012-07-12 Revised Date: 2014-09-18|
Medline Journal Info:
|Nlm Unique ID: 0410462 Medline TA: Nature Country: England|
|Languages: eng Pagination: 593-8 Citation Subset: IM|
|APA/MLA Format Download EndNote Download BibTex|
Biological Markers / analysis
Cicatrix / pathology, therapy
Fibroblasts / cytology*, drug effects, metabolism, pathology
GATA4 Transcription Factor / genetics, metabolism
Gene Expression Regulation
Genetic Vectors / genetics
Heart / physiology, physiopathology
MEF2 Transcription Factors
Myocardial Infarction / drug therapy, pathology, physiopathology, therapy
Myocardium / cytology, pathology
Myocytes, Cardiac / cytology*, drug effects, metabolism, physiology*
Myogenic Regulatory Factors / genetics, metabolism
Regenerative Medicine / methods*
T-Box Domain Proteins / genetics, metabolism
Thymosin / pharmacology, therapeutic use
|C06RR018928/RR/NCRR NIH HHS; K08HL101989/HL/NHLBI NIH HHS; R01 HL060714/HL/NHLBI NIH HHS; R01 HL060714/HL/NHLBI NIH HHS; R01 HL060714-13/HL/NHLBI NIH HHS; U01 HL100406/HL/NHLBI NIH HHS|
|0/Biological Markers; 0/GATA4 Transcription Factor; 0/Gata4 protein, mouse; 0/MEF2 Transcription Factors; 0/Mef2c protein, mouse; 0/Myogenic Regulatory Factors; 0/T-Box Domain Proteins; 0/T-box transcription factor 5; 61512-21-8/Thymosin; 77591-33-4/thymosin beta(4)|
Circ Res. 2012 Sep 14;111(7):831-2
Circ Cardiovasc Genet. 2012 Aug 1;5(4):481-2 [PMID: 22896018 ]
Nature. 2012 May 31;485(7400):585-6 [PMID: 22660313 ]
Cell Stem Cell. 2012 Jul 6;11(1):3-4 [PMID: 22770235 ]
Journal ID (nlm-journal-id): 0410462
Journal ID (pubmed-jr-id): 6011
Journal ID (nlm-ta): Nature
Journal ID (iso-abbrev): Nature
nihms-submitted publication date: Day: 23 Month: 3 Year: 2012
Print publication date: Day: 31 Month: 5 Year: 2012
pmc-release publication date: Day: 30 Month: 11 Year: 2012
Volume: 485 Issue: 7400
First Page: 593 Last Page: 598
PubMed Id: 22522929
|In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes|
|C. Ian Spencer123|
|Simon J. Conway6|
1Gladstone Institute of Cardiovascular Disease, University of California, San Francisco, CA 94158
2Department of Pediatrics, University of California, San Francisco, CA 94158
3Department of Biochemistry and Biophysics, University of California, San Francisco, CA 94158
4Cardiovascular Research Institute, University of California, San Francisco, CA 94158
5Department of Medicine, University of California, San Francisco, CA 94158
6Developmental Biology and Neonatal Medicine Research Program, Indiana University School of Medicine, Indianapolis, IN 46202, USA
|Correspondence: Correspondence: Deepak Srivastava, Gladstone Institute of Cardiovascular Disease,1650 Owens Street, San Francisco, CA 94158, USA, Phone:(415) 734-2716, Fax: (415) 355-0141, email@example.com
Heart failure affects over 14 million people worldwide and is a leading cause of death in adults and in children. Because postnatal cardiomyocytes (CMs) have little or no regenerative capacity, current therapies are limited. The introduction of exogenous stem cell–derived CMs holds promise, but also challenges, including delivery, integration, rejection, and cellular maturation1–3. Reprogramming adult fibroblasts into induced pluripotent stem (iPS) cells that are similar to embryonic stem (ES) cells addresses some issues4–6, but others, including efficient directed differentiation into CMs and effective delivery, remain.
A new generation of reprogramming technology involves trans differentiating one adult somatic cell type directly into another7–11. We reported direct reprogramming of fibroblasts into CM-like cells in vitro by expressing three transcription factors: Gata4, Mef2c, and Tbx5 (GMT)7. As observed in reprogramming to iPS cells, the percentage of fibroblast cells fully reprogrammed to beating CMs in vitro was small, but far more were partially reprogrammed, much like pre-iPS cells that can become fully pluripotent with additional stimuli12. We posited that cardiac fibroblasts may reprogram more fully in vivo in their native environment, which might promote survival, maturation, and coupling with neighboring cells. If so, the vast pool of cardiac fibroblasts in the heart could serve as an endogenous source of new CMs for regenerative therapy.
We used a retroviral system to express GMT, and/or dsRed as a marker, in the hearts of 2-month-old male mice by direct intra myocardial injection. After 2days, transverse sections of the injected area were prepared and co-stained for dsRed, α-Actinin (a CM marker), and Vimentin (enriched in fibroblasts). No markers are uniquely specific for cardiac fibroblasts, but fibroblasts are known to express Vimentin and the surface markers Thy1 and DDR213. At baseline, it was difficult to detect α-Actinin- or Vimentin-positive cells that also expressed dsRed, suggesting minimal viral uptake, and consistent with the observation that retroviruses only infect actively dividing cells14.
Fibroblasts are embryo logically distinct from CMs in their origin15, and following myocardial infarction (MI) become activated, migrate to the injury site, and proliferate16,17. We induced cardiac injury by coronary artery ligation and injected dsRed retrovirus into the myocardium bordering the infarct zone. While cells co-expressing dsRed and α-Actinin were still undetectable, many Vimentin-positive cells were also positive for dsRed (Suppl. Fig. 1). By fluorescence-activated cell sorting (FACS), over 4% of cells (98,238 ± 5523) from the left ventricle of injected hearts were dsRed+Thy1+ 2 days after injury, suggesting successful delivery of virus into cardiac fibroblasts and possibly other non-myocytes upon injury (Fig. 1a,b). By quantitative (q)PCR, dsRed+Thy1+-sorted cells expressed 60-fold moreGata4, Mef2c, and Tbx5 than dsRed−Thy1+ cells, and 6–8-fold more than endogenous CMs (Fig. 1c). A similar number of dsRed+Thy1− cells represented other non-myocyte cell types. Endothelial cells (PECAM+) and some peri-vascular cells (NG2+) were also transduced by the retrovirus, but hematopoietic (CD34+) and pericardial (WT1+) cells were not (Suppl. Fig. 1).
To determine if new cardiomyocytes could be created in vivo from cells other than post-mitotic CMs, we used lineage-tracing experiments to track the origin of putative induced cardiomyocytes (iCMs). To genetically label cells, we used a mouse transgenic line that expresses Cre-recombinase under the promoter of the fibroblast-enriched gene, Periostin15,18,19. When intercrossed with the R26R-lacZ reporter line20, in which β-galactosidase is activated only in Periostin-Cre-expressing cells and their progeny (Fig. 1d-f), we found β-galactosidase activity in many, but not all, cardiac fibroblasts and some endocardial and endothelial cells, as reported15,18,19. Periostin-Cre activity was absent in bone marrow cells (not shown). β-Galactosidase activity was not detected in any cardiomyocytes, even 4 weeks after injury, consistent with thoracic aortic banding studies, confirming that the Periostin-Cre mice faithfully marks descendants of the non-myocyte population, even after infarct (Fig. 1e)15,18,19. Isolation of single CMs from these hearts confirmed absence of β-Galactosidase activity in over 1500 CMs/heart from 6 mice.
In contrast, 4 weeks after MI and retroviral delivery of GMT, numerous β-galactosidase+ cells were α-Actinin+ in the injured areas, with well-formed sarcomeres and shapes similar to β-galactosidase− myocytes, suggesting they were descendants of cells that once expressed Periostin (Fig. 1f). Similar results were obtained using transgenic mice in which Cre-recombinase was under the control of the fibroblast-specific protein 1 (Fsp1) promoter21 to label the non-myocyte population (Fig. 1g and Suppl. Fig. 2a–f). Thus, like MyoD inducing the conversion of cardiac fibroblasts into skeletal muscle in vivo23, GMT appeared to induce the formation of cardiomyocytes in vivo. We determined if endothelial and circulating hematopoietic cells marked by Tie2-Cre:R26R-lacZ22 transgenic mice could be reprogrammed to express sarcomeric markers, but found no evidence for such an event (Suppl. Fig. 2g–i).
We formally tested whether retroviral introduction of GMT into non-myocytes could promote cell fusion events in the heart, thereby generating α-Actinin+:β-galactosidase+ cells. We “pulse-labeled” endogenous CMs in transgenic mice with Cre under inducible control of the αMHC promoter (αMHC-MerCreMer)24 crossed with R26R-EYFP mice (Suppl. Fig. 3). Subsequently, hearts were injured and infected retrovirally with GMT and dsRed to mark infected dividing cells. After 4 weeks, we detected no YFP+ cells co-labeled with dsRed in the GMT dsRed-or dsRed-infected hearts (Fig. 2a, b, and Suppl. Fig. 4a). Since pulse-labeling marks only ~80% of endogenous CMs in the uninjured heart and ~60% in the infarct border zone25, we quantified the percentage of YFP+ pulse–labeled endogenous CMs at the border area. GMT introduction resulted in a reduced percentage of YFP+ endogenous CMs compared to total CMs, indicating that the CMs in this region were refreshed by new iCMs (Fig. 2c). These findings suggest that it is unlikely that cell fusion makes a major contribution to the α-Actinin+:β-galactosidase+ cell population, although a minor contribution cannot be ruled out.
If α-Actinin+:β-galactosidase+ cells instead resulted from cellular reprogramming, one might detect progressive stages of reprogramming over time, as cell fusion would yield mature cells soon after fusion without intermediate stages. We therefore analyzed heart sections 1, 2, 3, and 4 weeks after injury and GMT infection, classified cells into four groups based on increasing α-Actinin expression and organization into sarcomeres. The number of α-Actinin+:β-galactosidase+ cells in the infarct area increased temporally, as did maturity of the cells, with progressive increases in the percentage of cells with well-developed sarcomeres (Suppl. Fig. 5).
To avoid false positives from overlaying cells due to the thickness of the heart sections, we isolated adult CMs at the single-cell level from the infarct/border zone of Periostin-Cre:R26R-lacZ reprogrammed hearts 4 weeks after coronary ligation (Suppl. Fig. 6a). In this preparation, non-myocytes were removed, and cells were assayed 2–4 hours after primary culture. No CMs isolated from dsRed-injected hearts were β-galactosidase+ by immunostaining (Fig. 2d). Similarly, CMs from Periostin-Cre:R26R-EYFP mice were all YFP−, among the thousands of cells visualized, in agreement with the absence of Periostin-Cre activity in myocytes after injury. In contrast,35% of cells in the CM preparation from the border/infarct zone were β-galactosidase+ after GMT injection (Fig. 2e,f, Suppl. Fig. 6b). Among the β-galactosidase+ cells, 98% were also α-Actinin+ (Suppl. Fig. 7a-d). Furthermore, in hearts co-injected with GMT and dsRed retrovirus, β-galactosidase+ CMs were also positive for dsRed, indicating retroviral infection and their likely origin from non-post-mitotic CMs (Fig. 2g–k).
Most β-galactosidase+ cells were large, rod-shaped, and binucleated, closely resembling endogenous CMs that were β-galactosidase− from the same preparation. In addition to α-Actinin, β-galactosidase+ cells expressed multiple sarcomeric markers, including Tropomyosin (Fig. 2m), αMHC(Fig. 2n), and cardiac Troponin T (cTnT) (Fig. 2o). Half of the cells had nearly normal sarcomeric structures throughout the cell. The full spectrum of reprogrammed cells, classified by quality of sarcomeric structure, is shown in Suppl. Fig. 7. Characterization of single dsRed+ YFP− cells derived from the α-MHC-Mer-Cre-Mer-YFP pulse-labeled reprogrammed hearts revealed good sarcomere formation and expression of α-Actinin, cTnT, and Connexin 43, like dsRed−YFP+ cells (Suppl. Fig. 4b).
By electron microscopy, about half of the cells from Periostin-Cre:R26R-Tomato reprogrammed hearts exhibited well-organized sarcomeres and mitochondria (Fig. 2p,q), although the sarcomeres were consistently shorter than endogenous CMs and their Z-bands more diffuse. Other Tomato+ cells displayed sarcomeric organization in parts of the cell and variable mitochondria organization (Suppl. Fig. 8). For simplicity, we will refer to the β-galactosidase+ α-Actinin+ CM-like cells as in vivo iCMs, based on morphology and sarcomeric structure.
Finally, we assessed the reprogramming of gene expression in iCMs by qPCR, focusing on the mRNA levels of 20 genes normally enriched in mature CMs or cardiac fibroblasts. We tested iCMs isolated from multiple independent hearts alongside cardiac fibroblasts and endogenous CMs. mRNA levels in iCMs were similar to CMs (Fig. 2r and Suppl. Fig. 9), including the down-regulation of Periostin and Fsp1, consistent with the morphologic changes described earlier.
To determine whether iCMs expressed proteins involved in cell-cell communication similar to endogenous CMs, we examined the expression pattern of N-Cadherin, a cell-surface Ca2+-dependent adhesion molecule normally found in intercalated disks within the myocardium26. We found that over 90% of iCMs expressed N-Cadherin, with 60% of cells localizing N-Cadherin appropriately at the cell border (Fig. 3a). Similarly, about 90% of iCMs expressed Connexin 43 (Cx43), the major gap junction protein in the heart that promotes electrical coupling and synchronized contraction of myocytes27. Half of the iCMs expressed Cx43 at high levels with good localization relative to endogenous CMs (Fig. 3b), and in 4% of these cells, the Cx43 localization pattern was almost indistinguishable from endogenous CMs (Fig. 3b). Immunohistochemistry also revealed good cell-border localization of Cx43 in iCMs (Fig. 3c).
To assess the function of cell-to-cell junctions, we imaged the transfer of dyes—microinjected via patch pipettes—between cells, and measured the intercellular transmission of excitation, via Ca2+ waves, in small groups of cells isolated from the reprogrammed hearts. Cascade Blue dextran (MW 10,000), which is too large to pass through gap junctions, was retained in the patched iCMs (identified by the lineage marker Periostin-Cre:R26R-Tomato). In contrast, calcein (MW 600) diffused to interconnected endogenous CMs (Fig. 3d). Ca2+ waves propagating in an iCM or CM excited intracellular Ca2+ release in neighboring cells (Fig. 3e), suggesting that iCM-CM couplings form functional syncytia (see Supplementary Movie 1).
We next performed recordings from a single-cell suspension of CMs isolated from the border/infarct zone of Periostin-Cre:R26R-EYFP mice transduced with GMT, and compared the action potentials generated by iCMs(YFP+) and endogenous CMs(YFP−) using standard patch-clamp techniques. Approximately 50% of patched iCMs had a physiological resting membrane potential (-70 mV or less) and 50% of iCMs exhibited contractions in response to electrical stimulation, similar to adult ventricular CMs, which are normally quiescent without stimulation (Fig. 3f and Supplementary Movie 2). Electrophysiology parameters assayed were similar to endogenous ventricular CMs (Fig. 3g). In agreement, intracellular calcium releases and cell shortening in iCMs were comparable to endogenous CMs (Fig. 3h). The distribution of action potential durations (APDs) was bimodal in iCMs and CMs, suggesting that reprogrammed cells were incorporated near the epicardial (short APD90) and endocardial (long APD90) sides of ventricular tissue (Suppl. Fig. 10).
Since in vivo reprogrammed iCMs had contractile potential and electrically coupled with viable endogenous CMs (and other iCMs), we asked whether converting endogenous non-myocytes into new myocytes translates into partial restoration of heart function after MI. All studies were performed in a blinded fashion, including the retroviral injections, and were de-coded only after completion of the measurements. By Evans blue/TTC double staining, the area-at-risk (AAR) and the myocardium infarct size were similar in GMT-or dsRed-injected mice 48 hours after coronary ligation (Suppl. Fig. 12a). Three months post-MI, cardiac function was examined by magnetic resonance imaging (MRI). The fraction of blood ejected with each ventricular contraction (ejection fraction), the volume of blood ejected (stroke volume), and the total cardiac output per minute were significantly improved in GMT-infected mice, particularly the stroke volume and cardiac output, possibly due to cardiac enlargement (Fig. 4a). To determine the time course of these improvements, other mice underwent serial high-resolution two-dimensional echocardiography 1 day before MI, and 3 days,1-, 4-, 8-, and 12-weeks post-MI (Supp. Fig. 11b-d). All mice showed a comparable reduction in left ventricular function after coronary artery ligation (Supp. Fig. 11c). Although different imaging approaches yield different absolute value norms, the overarching trends observed by echocardiography were similar to our MRI findings, in that functional improvements for all parameters were statistically significant 8 and 12 weeks post-injection (Supp. Fig. 11c).
We next performed qPCR to monitor the expression levels of atrial natriuretic factor, brain natriuretic peptide and tenascin C in injured and control hearts. We found that MI led to the upregulation of all three peptides, but this upregulation was attenuated in GMT-injected infarcted hearts (Fig. 4b). Expression levels of collagen genes, which were increased in uninfected MI hearts, were also partially restored by injecting GMT (Fig. 4c). Furthermore, the scar area calculated from 16 sections at four levels of the heart was significantly smaller 8 weeks after MI in the GMT-treated group. To determine if the muscle cells in the scar area were reprogrammed iCMs, we repeated the experiments in Periostin-Cre:R26R-LacZ transgenic mice. α-Actinin+ cells in the scar area were also β-Galactosidase positive, suggesting that they were newly born iCMs of non-myocyte origin (Fig. 4e). Vascular density was significantly increased in the border zone of reprogrammed hearts at 8 weeks (Suppl. Fig. 12). Electro cardiographic (ECG) studies (telemetry) over a24-hour period did not indicate evidence for more arrhythmias in GMT- versus dsRed-injected control mice, and no mice suffered sudden death (not shown).
We hypothesized that infecting more Thy1+ cells would enhance functional improvement. Thymosin β4, a 43-amino-acid G-actin monomer-binding protein, promotes cell migration28,29, cardiac cell survival28,30 and activates epicardial cells to become more proliferative and yield more cardiac fibroblasts and endothelial cells31,32. It also improves cardiac function and decreases scar size after MI28. To test cardiac fibroblast migration, we used a cardiac explant migration assay7,28. The average time for fibroblasts to migrate from adult heart explants was 3 weeks; however, Thymosin β4treatment led to equivalent fibroblast migration within 2 weeks and within only 3 days in heart explants taken after MI Fig. 5a. Similarly, Vimentin+ cell proliferation was even more pronounced post-MI in the presence of Thymosin β4, as marked by phosphohistone H3 (Suppl. Fig. 13b). The percentage of Thy1+ (Suppl. Fig. 13c) or Vimentin+ (Suppl. Fig. 14a) cells infected by retrovirus after MI doubled upon intra myocardial Thymosin β4injection (316,607 ± 17,799 dsRed+ cells averaged from three hearts). GMT did not increase the number of cardiac fibroblasts (Suppl. Fig. 13d). Delivering GMT-expressing retrovirus to more cells by adding Thymosin β4 yielded more βGal+ iCMs compared to total CMs in single-cell CM culture from the infarct/border zone of Periostin-Cre:R26R-lacZ hearts (51% vs. 35%) (Suppl. Fig. 13e). However, we observed no change in the degree or efficiency of in vivo reprogramming, with the percentage of iCMs generated from the total GMT-infected cell population remaining at ~12% (Suppl. Fig. 13e, Suppl. Fig. 14b).
Injecting Thymosin β4 immediately after ligation improved cardiac function, as reported28,30. Co-injecting Thymosin β4 and GMT further improved ejection fraction and cardiac output 8 weeks after infarction (Suppl. Fig. 13f and Suppl. Fig. 14d,e). Furthermore, co-injecting Thymosin β4 and GMT caused less scarring than injecting either alone (Suppl. Fig. 13g), despite similar areas at risk and initial infarct sizes (Suppl. Fig. 14c).
We show that upon cardiac injury, resident cardiac non-myocytes—primarily fibroblasts—can be converted into CM-like cells in vivo following local delivery of GMT by retroviral-mediated gene transfer. In vivo cardiac reprogramming occurred with similar initial efficiency as observed in vitro (10–15%). However, in vivo iCMs were more fully reprogrammed and more closely resembled endogenous CMs than their cultured counterparts. This may result from factors within the native microenvironment—including extracellular matrix, secreted proteins, and tissue stiffness—that further enhance reprogramming. Improved cardiac function may be explained by the diversion of a small percentage of fibroblasts into new CM-like cells, suggesting functional integration of these muscle cells. Although non-myocytes convert to iCMs to help regenerate the damaged heart, alteration of fibroblast behavior by GMT may contribute to the effects on scar formation and cardiac function. While it is difficult to separate the relative contributions of new muscle formation and other non-cell-autonomous effects, non-myocyte reprogramming in the heart appears to be beneficial for cardiac function. Optimizing gene delivery to more cells would likely enhance functional benefits.
Improvement upon Thymosinβ4 addition is in agreement with the notion that increasing the delivery of GMT to more cells could enhance cardiac repair. Pre-treating hearts with Thymosin β4 several days before injury resulted in a small population of epicardial-derived cells that could behave as myocyte precursors, but not if Thymosin β4 was given at the time of injury33. Nevertheless, transduction of GMT into these progenitors, or other rare progenitors yet to be identified, might promote their differentiation into cardiomyocytes. Since Thymosin β4 is also pro-angiogenic31,32, the cooperativity between GMT and Thymosin β4 may be multi-faceted and will be interesting to explore.
The ability to regenerate adult heart tissue from endogenous cells is a promising approach to treating cardiac disease that may face fewer obstacles to clinical translation than other approaches. Improving the delivery of reprogramming factors, using small molecules and epigenetic modulators, and conducting trials in large animals will be important to refine the technology and assess its safety and efficacy, particularly regarding arrhythmias.
Retroviruses were generated as described7 using pMXs retroviral vectors containing coding regions of Gata4, Mef2c, Tbx5, and dsRed. Ultra-high titer virus (>1×1010 plaque-forming units (p.f.u) per ml) was obtained by ultracentrifugation.
Periostin (Postn)-Cre:R26R-lacZ or Fsp1-Cre:R26R-lacZmice were obtained by crossing Periostin-Cre mice19 or Fsp1-Cre mice21 and R26R-lacZ mice20. Postn-Cre:R26R-EYFP or αMHC-MerCreMer:R26R-EYFP mice were obtained by crossing Periostin-Cre or αMHC-MerCreMer24 mice and R26R-EYFP mice. Postn-Cre:R26R-Tomato mice were obtained by crossing Periostin-Cre mice and R26R-Tomato mice. Surgeries and subsequent analyses were performed blinded to genotype and intervention. MI was induced by permanent ligation of the left anterior descending artery (LAD)as described34. A pool of concentrated virus (GMT or GMTR) was mixed, and 10 μl of mixed virus plus 10 μl of PBS or 40 ng/μl Thymosin β4 were injected along the boundary between the infarct and border zones. Mouse echocardiography and surface electrocardiography were performed as described34. All mouse work was done with approval of the UCSF animal care oversight committee.
Immunohistochemistry, immunocytochemistry, and electron microscopy (EM) were performed as described34,35. Scar size was determined by Masson-Trichrome staining28,34. The AAR and myocardial infarct size were determined by Evans Blue/triphenyltetrazolium chloridelabeling34.
Adult cardiomyocytes were isolated as described with minor modifications36. Single-cell patch clamp recordings were performed as described37. Migration assays were performed according to published protocols7,28.
Dissociated cardiac cells were stained with APC-conjugated anti-Thy1 antibody (eBioscience). Stained cells were sorted by FACSAria2 (BD) and RNA extracted in TRizol (Invitrogen). qPCR was performed using ABI 7900HT (TaqMan, Applied Biosystems).
Differences between groups were examined for statistical significance using unpaired student’s t-tests or ANOVA. p < 0.05 was regarded as significant.
Retroviruses were generated as described. To generate virus, pMXs retroviral vectors containing the coding regions of Gata4, Mef2c, Tbx5, and dsRed were transfected into Plat-E cells using Fugene 6 (Roche). 48 hours after transfection, virus-containing supernatants were collected and concentrated by standard ultracentrifugation. Retroviral titration was performed using the Retro-X qRT-PCR Titration Kit (Clontech), as per the manufacturer’s protocols. Ultra-high titer virus (>1×1010 plaque-forming units [p.f.u] per ml) was resuspended in PBS. After verification of high transduction efficiency in cell culture (>95%), a large number of small stock aliquots (10 μl) were made and frozen at −80°C to ensure consistency among experiments. After one freeze-thaw cycle, titrations were repeated to ensure that active virus was maintained at the desired 1×1010 p.f.u concentration for in vivo injection.
Periostin (Postn)-Cre:R26R-lacZmice were obtained by crossing Postn–Cre mice and Rosa26-lacZ mice. Postn-Cre:R26R-YFP mice were obtained by crossing Postn–Cre mice and Rosa26-EYFP mice, and Postn-Cre:R26R-Tomato mice were obtained by crossing Postn-Cre mice and Rosa26-Tomato mice. All transgenic lines were maintained by crossing with C57BL6 mice (Charles River) for immunohistochemistry (IHC) and single cell isolation. BALB/C mice (Charles River) were used for all functional studies after LAD and virus injection. Fsp1-Cre, Tie2-Cre and Myh6-MerCreMer mice were obtained from Jackson Labs, and lines were validated before further breeding. Fsp1-R26R, Tie2-R26R, and Myh6-MerCreMer-YFP mice were obtained by crossing Fsp1-Cre, Tie2-Cre or Myh6-MerCreMer mice to R26R-lacZ or R26R-EYFP mice. Efficiency of Cre recombination induction for Myh6-MerCreMerYFP was tested by IHC for YFP after injection of various doses of tamoxifen. To “pulse” label the pre-existing CMs, adult Myh6-MerCreMerYFP mice (8–12 weeks old) were treated with tamoxifen (Sigma) by intraperitoneal injection once a day for 5 days at a dosage of 20 mg/kg/day. GMT delivery and coronary artery ligation were performed 2 days afterwards.
The animal protocol for surgery was approved by institutional guidelines (UCSF Institutional Animal Care and Use Committee). All surgeries and subsequent analyses were performed blinded for genotype and intervention. Mice were anesthetized with2.4% isoflurane/97.6% oxygen and placed in a supine position on a heating pad (37°C). Animals were intubated with a 19 G stump needle and ventilated with room air using a MiniVent Type 845 mouse ventilator (Hugo Sachs Elektronik-Harvard Apparatus, Germany; stroke volume 250 μl, respiratory rate 120 breaths/minute). MI was induced by permanent ligation of the left anterior descending artery (LAD) with a 7-0 prolene suture as described28. Sham-operated animals served as surgical controls and were subjected to the same procedures as the experimental animals with the exception that the LAD was not ligated. A pool of concentrated virus (Gata4/Mef2c/Tbx5 [GMT] or Gata4/Mef2c/Tbx5/dsRed [GMTR]) was mixed, and 10 μl of mixed virus plus 10 μl of PBS or 40 ng/μl Thymosin β4 was injected into the myocardium through an insulin syringe with an incorporated 29G needle (BD). Injection with a full dosage was carried out along the boundary between the infarct zone (IZ) and border zone (BZ) based on the blanched infarct area after coronary artery occlusion. After injection, the chest was closed with sutures and the mouse was allowed to recover with the mouse ventilator and heating pad. All surgical procedures were performed under aseptic conditions. At 2 days and 1, 2, 4, 8, and 12 weeks after occlusion and viral delivery, the hearts were removed for perfusion fix in 4% paraformaldehyde (PFA) for preparation of paraffin sections for structural analysis and immunohistochemistry or in 0.5% PFA in 5% sucrose followed by cryostat sectioning for immunofluorescent staining. Concurrently, heart tissues within the infarct zone (IZ), border zone (BZ) and non-ischemic zone distal to the infarct zone (DZ) were dissected for RNA or protein isolation.
At 48hours after coronary ligation, the mice were anesthetized and cannulated with tubing. Evans Blue (2%, Sigma) was perfused into the aorta, thus all myocardial tissue was stained blue except the AAR. The LV was isolated and cut into four ~1 mm pieces with the first cut at the ligation level. LV slices were stained in 1.5% triphenyltetrazolium chloride (TTC) for 30 min at 37 C, and then fixed in 4% PFA overnight at 4 C. The area of infarction was demarcated as a white area, while viable myocardium was stained red. Photographs were taken from both sides of each section. The AAR and the infarct area were determined via planimetry with the computer software ImagePro (Biorad). Infarct size was calculated as the percentage of myocardial infarction compared with the AAR using the described methodology38.
Standard Masson-Trichrome staining was performed on hearts 8 weeks post-viral delivery and coronary artery ligation. To determine the scar size, we used ImagePro software to measure the scar area (blue) and healthy area (red) on transverse sections spanning four levels (50 mm between two levels, with the first level starting right below the ligation) within the left ventricle of a MI heart. From each level, we measured four slices of tissues as technical quadruplicates (for a total of 16 sections). The averaged number was used for statistics and comparison. The measurements and calculations were conducted in a blinded manner.
Echocardiography was performed by the Vevo 770 High-Resolution Micro-Imaging System (VisualSonics, Toronto, Canada) with a 15-MHz linear array ultrasound transducer. The left ventricle (LV) was assessed in both parasternal long-axis and short-axis views at a frame rate of 120 Hz. End-systole or end-diastole was defined as the phase in which the smallest or largest area of LV, respectively, was obtained and used for ejection fraction measurement. Left ventricular end-systolic diameter (LVESD) and left ventricular end-diastolic diameter (LVEDD) were measured from the LV M-mode tracing with a sweep speed of 50 mm/s at the papillary muscle level for calculating the shortening fraction. B-mode was used for two-dimensional measurements of end systolic and end diastolic dimensions.
Mice were anesthetized with 1.75% isoflurane at a core temperature of 37–38°C. Four needle electrodes (AD Instruments) were placed subcutaneously in standard limb lead configurations. For each mouse, 10–20 seconds of continuous signals were sampled at 10 KHz in each lead configuration with a PowerLab4/30 interface (AD Instruments). Data analysis was performed offline with electronic calipers on averaged beats (Chart5Pro v5.4.2, AD Instruments).
To record awake electrocardiograms in six reprogrammed post-MI mice and six control post-MI mice, transmitters were surgically implanted according to the manufacturer’s instructions (Data Sciences International, St. Paul, MN). After a 3-day recovery period, the electrocardiogram was recorded continuously for 48 hours in each mouse. Tracings were analyzed off-line and were scored by a blinded investigator for the presence and frequency of arrhythmias.
MRI was performed on a Varian DirectDrive 7T small-animal scanner (Varian, Palo Alto, CA, USA). Each mouse was anesthetized by inhalation of 2% isoflurane/98% oxygen administered via an MR-compatible mobile inhalation anesthesia system (Vet Equip, Pleasanton, CA, USA). The mice were put in supine position on a homemade heating bed to keep the temperature at 37°C. Two ECG leads were inserted into the right front and left rear leg. ECG waveforms were monitored with a small animal monitoring and gating system (SA instruments, Stony Brook, NY, USA). The mouse was then placed into a homemade 1H birdcage coil with an inner diameter of 32 mm. A group of ECG- (R-wave rising edge) triggered spin echo scout images were acquired first to define the oblique plane of the short-axis. Then an ECG-triggered 2D gradient echo sequence with an echo time of 2.75 ms, repetition time of 200 ms and a flip angle of 45° was used to obtain nine short-axis images at 12 or 13 phases per cardiac cycle. Each scan consisted of 8–9 contiguous slices spanning the LV from apex to base with 1-mm thickness, a matrix size of 128×128, a field of view of 25.6 × 25.6 mm, and four averages.
Adult cardiomyocyte isolation was performed as described with minor modifications36. Briefly, adult mice were anesthetized with isoflurane and mechanically ventilated. Hearts were removed and perfused retrogradely via aortic cannulation with a constant flow of 3 ml/min in a Langendorf apparatus. Hearts were perfused at 37°C for 5 min with supplemented Wittenberg Isolation Medium (WIM) containing (in mM): 116 NaCl, 5.4 KCl, 6.7 MgCl2, 12 glucose, 2 glutamine, 3.5 NaHCO3, 1.5 KH2PO4, 1,0 NaH2PO4, 21 HEPES, with 1.5 nM insulin, essential vitamins (GIBCO), and essential amino acids (GIBCO) (pH 7.4), followed by digestion solution (WIM, supplemented with 0.8 mg/ml colleganse II and 10 μM CaCl2) for 10 min(4 min for paired CMs that were used in cell-cell coupling experiments). Hearts were then removed from the Langendorf apparatus while intact (with tissues loosely connected). Desired areas (i.e. border/infarct zone) were then micro-dissected under the microscope, followed by mechanical dissociation, triturating, and resuspension in a low-calcium solution (WIM, supplemented with 5 mg/ml BSA, 10 mM Taurine, and 150 μM CaCl2). Cells were then spun at low speed, supernatant was removed, and calcium was gradually reintroduced through a series of washes. For electrophysiology experiments, cells were used on the same day as isolation and until recording were stored at room temperature in M199 (Gibco) supplemented with 5 mM creatine, 2 mM L-carnitine, 5 mM Taurine, and 1.5 nM insulin. For immunohistochemistry, cells were plated onto laminin-coated culture slides, allowed to adhere, and fixed on the day of isolation. For EM or qPCR, iCMs were selected manually by micro-pipette based on the presence of Periostin-Cre:R26R-YFP/Tomato signal under the fluorescent microscope right after isolation.
The migration assay was performed according to the explant culture protocol as described. In brief, isolated adult mouse hearts were minced into small pieces less than 1 mm3 in size. The explants were plated on gelatin-coated dishes and cultured in explant medium (IMDM/20%FBS)until fibroblasts migrated out from minced tissue. The time required for 10 heart pieces to have migratory fibroblasts surrounding them were recorded.
At 48 hours after LAD and viral introduction, hearts were removed and minced into small pieces less than 1 mm3 in size. Blood cells and debris were removed by several washings of PBS. Minced cardiac tissues were digested in an eppendorf tube and shaken with glass beads in enzyme buffer (Collagenase/Dispase[Roche] plus DNaseI [Roche]) at 37°C. After passing through a 40-μm cell strainer, dissociated cardiac cells were stained with APC-conjugated anti-Thy1 antibody (eBioscience) for 30 min at room temperature. After washing with PBS twice, stained cells were sorted by FACSAria2 (BD).
For immunofluorescence, after perfusion-fixed hearts were taken out and fixed in 0.5% paraformaldehyde(PFA)overnight, ventricles below the ligation were embedded in OCT compound and frozen in liquid nitrogen. Sections were blocked in Universal Blocking Buffer (BioGenex) for 10 min, and then stained with primary antibodies against α-Actinin (Sigma Aldrich), Vimentin (Progen), βGal (Abcam), pH3 (Millipore), RFP (Biovision), Thy1 (BD), CD34 (Abcam), WT1 (Abcam), PECAM (BD), NG2 (Millipore), and GFP (Invitrogen) for 1 hour at room temperature. After washing three times with PBST (PBS + 0.1% Triton), sections were incubated in secondary antibodies for 1 hour followed by washing an additional three times with PBST. Finally, the sections were mounted in Vectashield with DAPI (Vector Laboratories).
Isolated cells plated on chamber slides were fixed in 4% PFA at 4°C overnight and washed with PBS twice. Cells were then incubated with primary antibodies against sarcomeric α-Actinin (Sigma Aldrich), cardiac TnT (Thermo Scientific), RFP (Biovision), Tropomyocin (Hybridoma Bank), MF20 (Hybridoma Bank), Connexin43 (Sigma Aldrich), N-Cadherin (Invitrogen), β-Gal (Abcam), smooth muscle actin (Sigma Aldrich), and Vimentin (Progen) for 1 hour at room temperature and washed with PBS three times, then incubated with secondary IgG antibodies conjugated to Cy488 or 594 (Jackson Immunoresearch) for 30 min. After washing with PBS, cells were mounted in Vectashield with DAPI.
For electron microscopy, cells were fixed in 2% glutaraldehyde, 1% paraformaldehyde in 0.1M sodium cacodylate buffer, pH 7.4, post fixed in 2% osmium tetroxide in the same buffer, en block stained with 2% aqueous uranyl acetate, dehydrated in acetone, infiltrated, and embedded in LX-112 resin (Ladd Research Industries, Burlington, VT). Samples were ultrathin sectioned on a Reichert Ultracut S ultramicrotome and counter stained with 0.8% lead citrate. Grids were examined on a JEOL JEM-1230 transmission electron microscope (JEOL USA, Inc., Peabody, MA) and photographed with the Gatan Ultrascan 1000 digital camera (Gatan Inc., Warrendale, PA).
Isolated myocytes suspended in tissue culture medium were transferred to a superfusion chamber (RC-26GLP; Warner Instruments, Hamden, CT) on the stage of a Nikon TiS inverted fluorescence microscope equipped with a dual wavelength microfluorometer (IonOptix, Milton, MA). Myocytes isolated from either Periostin-Cre:R26R-YFP or Periostin-Cre:R26R-Tomato hearts after GMT infection were identified as control cardiomyocytes (CMs)or induced CMs (iCMs)on the basis of Tomato fluorescence (Texas red optics with exciter 560±55 nm, emitter 645±75 nm) or YFP (standard FITC optics), and were chosen for study if they lacked spontaneous beating and partial contractures. The myocytes were whole-cell patch-clamped using an Axopatch 200B amplifier and pClamp software (Molecular Devices Inc., Sunnyvale, CA). Patch electrodes of 2–5 MegOhms (1B-150F; WPI, Sarasota, FL) were filled with intracellular solution containing 120mM KCl, 20mMNaHEPES, 10mM MgATP, 5mM K2EGTA(or 0.1 mM), 2mM MgCl2, and adjusted to pH 7.1 with KOH. The cells were superfused with a modified Tyrode’s extracellular solution containing 137mM NaCl, 10mM NaHEPES, 10mMdextrose, 5mM KCl, 2mM CaCl2, 1mM MgCl2, adjusted to pH 7.4 with NaOH. After gigaOhm seal formation, whole-cell access to the myocyte was established by applying brief pressure pulses, and the amplifier was switched to current clamp mode, where upon the cell’s resting potential developed. Action potentials were stimulated at 0.33 Hz using 2 nA, 2 ms current pulses applied through the patch pipette, and were signal averaged in tens. All membrane potentials were corrected for a -5.6 mV liquid junction potential determined via pClamp software. Finally, the amplifier was switched back to voltage clamp mode to identify individual ion channel currents as required. In some experiments, the concentration of K2EGTA in the intracellular solution was reduced to 0.1 mM to permit excitation-contraction (EC) coupling to occur, and 100 μM K5Fluo-4 (Invitrogen Corp, Carlsbad, CA) was added to define the presence of cytosolic Ca2+ transients during action potentials. Electrophysiology data were digitized at 5 kHz and low-pass filtered at 2 kHz. Analysis was performed using pClamp, Microsoft Excel, and Origin (OriginLab, Northampton, MA) software. Action potential duration was measured from the point of maximum depolarizating voltage change (+dV/dtMax) to 50, 70, and 90% repolarization. Unless stated, experiments were performed at room temperature (21°C).
Isolated myocytes were loaded with Fluo-4 for 30 min at room temperature before being transferred to the superfusion chamber. The loading solution contained a 1:10 mixture of 5 mM Fluo-4 AM in dry DMSO and PowerloadTM concentrate (Invitrogen Corp) which was diluted 100-fold into extracellular Tyrode’s solution containing suspended myocytes. An additional twenty minutes was allowed for de-esterification before commencing recordings. Contractions and Ca2+ transients were evoked by applying voltage pulses at 0.33 Hz, between platinum wires placed on either side of the cell of interest and connected to a field stimulator (IonOptix, Myopacer). The pulses were of 2 ms duration and set at 150% of the threshold required to elicit twitches. Fluo-4 fluorescence transients were recorded via a standard filter set (#49011 ET, Chroma Technology Corp., Bellows Falls, VT) in batches of 10to enable signal averaging. Between stimuli, the fluorescence excitation light was blocked by an electromechanical shutter (CS35; Vincent Associates, Rochester, NY). Resting fluorescence was recorded after cessation of pacing, and background light was obtained after picking up and removing the cell from the field of view with a patch electrode at the end of the experiment. The Ca2+ transients were calibrated using the pseudo-ratio method39, assuming an in situ dissociation constant of 1.1 μM for Fluo-440. Contractions were optically recorded simultaneously with Ca2+ transients by illuminating the cell of interest in red light (λ> 665 nm) subsequently directed to a CCD camera (IonOptix Myocam). The cell length signals were converted to voltage via a video motion director (VED 205; Crescent Electronics, Sandy, UT) and contraction amplitudes from different myocytes were normalized by calculating the percent change in cell length.
In experiments to assess the interconnectivity between iCMs and CMs, the whole-cell patch clamp method was used to introduce a gap junction-permeable (i.e., mobile) and an impermeable (i.e., immobile) dye into the same cell of interest within a small group of apparently coupled isolated myocytes (n=5 groups from 5 independent hearts). The mobile dye was calcein (5mM), and the immobile dye was 1 mM dextran-conjugated Cascade Blue(M.W. 10000). The immobile dye was chosen to be well separated spectrally, both from calcein and from tomato, which was used for labeling iCMs (Invitrogen Corp). The dye pair was included in standard intracellular solution (containing 5 mM EGTA) and cytoplasmic loading was allowed to proceed for 2 min, after which the patch electrode was withdrawn from the patched myocyte. The sarcolemma of the cell re-sealed after pulling off the pipette, aided by high EGTA levels in the filling solution, thereby trapping the dyes in the cytoplasm. Blue fluorescence from the immobile indicator was excited at 365±40 nm, while calcein fluorescence was excited at 470±40 nm. Fluorescent images were recorded using IonOptix Myocam via a video frame grabber (#166VCB, Hauppage, Hauppage, NY) for processing using ImageJ software.
The functionality of cell-to-cell junctions was investigated by imaging the intercellular transmission of Ca2+ waves and excitation between myocytes pre-loaded with Fluo-4 AM as detailed above for the field-stimulation studies. Superfusion with 2 μM ouabain for 5–10 min was employed to induce intracellular Ca2+ overload accompanied by Ca2+ wave activity, and videomicroscopy revealed the spatiotemporal relationships of Ca2+ waves translocating within and between the individual cells imaged in small, adherent groups (n=6 groups from 5 independent hearts).
iCMs were manually sorted based on the presence of fluorescent lineage markers. ~100 iCMs were pooled for RNA isolation. Similarly, ~100 endogenous CMs isolated using the standard Langendorf apparatus(see above) and ~500 cardiac fibroblasts using the migration assay (see above) were prepared for RNA isolation. RNA was extracted by the TRizol method (Invitrogen). RT-PCR was performed using the Superscript III first-strand synthesis system (Invitrogen). qPCR was performed using the ABI 7900HT (TaqMan, Applied Biosystems) as per the manufacturer’s protocols. Optimized primers from Taqman Gene Expression Array were used.
Differences between groups were examined for statistical significance using unpaired student’s t-test or ANOVA. A p-value < 0.05 was regarded as significant. Error bars indicate standard error of the mean (SEM).
L.Q. designed, supervised and performed the experiments. Y.H. performed all surgeries, echoes and ECGs, and contributed to tissue sectioning and sample preparation. I.S. performed all cellular electrophysiology experiments. A.F. quantified scar size and induced cardiomyoyctes and helped with mouse colony maintenance. V.V. helped with isolation of adult cardiomyocytes and implantation of transmitters. S.J.C. provided Periostin-Cre:Rosa26-lacZ mice and supplemental data. J.F. provided initial reagents and technical knowledge and helpful discussion. D.S. designed and supervised the work. L.Q. and D.S. wrote the manuscript.
We are grateful for expert technical assistance from the Gladstone Histology Core (C. Miller), Gladstone Genomics Core (L. Ta, Y. Hao, B. Chadwick), UCSF MRI Core (M. Wendland, J. Hawkins) and Laboratory for Cell Analysis at UCSF (S. Elmes). We thank all the members of the Srivastava lab for helpful discussions; G. Howard and B. Taylor for editorial help; and B. Bruneau and B. Conklin for helpful discussions and critical reviews of the manuscript. We also thank J. Nerbonne, N. Foeger, and members of the Nerbonne laboratory for assistance with the adult myocyte isolation protocol. L.Q. is a postdoctoral scholar of the California Institute for Regenerative Medicine (CIRM). V.V. is supported by grants from the GlaxoSmithKline Research and Education Foundation and the NIH/NHLBI (K08HL101989). J.F. is supported by a postdoctoral fellowship from American Heart Association. S.J.C. was supported by R01 HL060714 from NHLBI/NIH. D.S. was supported by grants from NHLBI/NIH, CIRM, the Younger Family Foundation, Roddenberry Foundation and Whittier Foundation. This work was supported by NIH/NCRR grant (C06 RR018928) to the Gladstone Institutes. D.S. is a member of the Scientific Advisory Board of iPierian, Inc., and RegeneRx Pharmaceuticals.
|1.||Murry CE,Keller G. Differentiation of embryonic stem cells to clinically relevant populations: Lessons from embryonic developmentCell132661680Year: 200818295582|
|2.||Passier R,van Laake LW,Mummery CL. Stem-cell-based therapy and lessons from the heartNature453322329Year: 200818480813|
|3.||Srivastava D,Ivey KN. Potential of stem-cell-based therapies for heart diseaseNature44110971099Year: 200616810246|
|4.||Takahashi K,Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factorsCell126663676Year: 200616904174|
|5.||Takahashi K,et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factorsCell131861872Year: 200718035408|
|6.||Yamanaka S,Blau HM. Nuclear reprogramming to a pluripotent state by three approachesNature465704712Year: 201020535199|
|7.||Ieda M,et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factorsCell142375386Year: 201020691899|
|8.||Szabo E,et al. Direct conversion of human fibroblasts to multilineage blood progenitorsNature468521526Year: 201021057492|
|9.||Vierbuchen T,et al. Direct conversion of fibroblasts to functional neurons by defined factorsNature46310351041Year: 201020107439|
|10.||Zhou Q,Brown J,Kanarek A,Rajagopal J,Melton DA. In vivo reprogramming of adult pancreatic exocrine cells to beta-cellsNature455627632Year: 200818754011|
|11.||Huang P,et al. Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factorsNature475386389Year: 201121562492|
|12.||Silva J,et al. Promotion of reprogramming to ground state pluripotency by signal inhibitionPLoS Biol6e253Year: 200818942890|
|13.||Ieda M,et al. Cardiac fibroblasts regulate myocardial proliferation through beta1 integrin signalingDev Cell16233244Year: 200919217425|
|14.||Byun J,et al. Myocardial injury-induced fibroblast proliferation facilitates retroviral-mediated gene transfer to the rat heart in vivoJ Gene Med2210Year: 200010765500|
|15.||Snider P,et al. Origin of cardiac fibroblasts and the role of periostinCirc Res105934947Year: 200919893021|
|16.||Baudino TA,Carver W,Giles W,Borg TK. Cardiac fibroblasts: Friend or foe?Am J Physiol Heart Circ Physiol291H10151026Year: 200616617141|
|17.||Camelliti P,Borg TK,Kohl P. Structural and functional characterisation of cardiac fibroblastsCardiovasc Res654051Year: 200515621032|
|18.||Snider P,et al. Periostin is required for maturation and extracellular matrix stabilization of noncardiomyocyte lineages of the heartCirc Res102752760Year: 200818296617|
|19.||Takeda N,et al. Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overloadJ Clin Invest120254265Year: 201020038803|
|20.||Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strainNat Genet217071Year: 19999916792|
|21.||Bhowmick NA,et al. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epitheliaScience303848851Year: 200414764882|
|22.||Kisanuki YY,et al. Tie2-Cre transgenic mice: A new model for endothelial cell-lineage analysis in vivoDev Biol230230242Year: 200111161575|
|23.||Murry CE,Kay MA,Bartosek T,Hauschka SD,Schwartz SM. Muscle differentiation during repair of myocardial necrosis in rats via gene transfer with MyoDJ Clin Invest9822092217Year: 19968941636|
|24.||Sohal DS,et al. Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre proteinCirc Res892025Year: 200111440973|
|25.||Hsieh PC,et al. Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injuryNat Med13970974Year: 200717660827|
|26.||Li J,et al. Cardiac-specific loss of N-cadherin leads to alteration in connexins with conduction slowing and arrhythmogenesisCirc Res97474481Year: 200516100040|
|27.||Saffitz JE,Laing JG,Yamada KA. Connexin expression and turnover: Implications for cardiac excitabilityCirc Res86723728Year: 200010764404|
|28.||Bock-Marquette I,Saxena A,White MD,Dimaio JM,Srivastava D. Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repairNature432466472Year: 200415565145|
|29.||Goldstein AL,Hannappel E,Kleinman HK. Thymosin beta4: Actin-sequestering protein moonlights to repair injured tissuesTrends Mol Med11421429Year: 200516099219|
|30.||Hinkel R,et al. Thymosin beta4 is an essential paracrine factor of embryonic endothelial progenitor cell-mediated cardioprotectionCirculation11722322240Year: 200818427126|
|31.||Smart N,et al. Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularizationNature445177182Year: 200717108969|
|32.||Bock-Marquette I,et al. Thymosin beta4 mediated PKC activation is essential to initiate the embryonic coronary developmental program and epicardial progenitor cell activation in adult mice in vivoJ Mol Cell Cardiol46728738Year: 200919358334|
|33.||Smart N,et al. De novo cardiomyocytes from within the activated adult heart after injuryNature474640644Year: 201121654746|
|34.||Qian L,et al. miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytesJ Exp MedYear: 2011|
|35.||Larsen TH,Saetersdal T,Grong K. The ultrastructure of the myocyte in different regions of experimental infarcts in the cat heartRes Exp Med186295306Year: 1986|
|36.||Xu H,Guo W,Nerbonne JM. Four kinetically distinct depolarization-activated K+ currents in adult mouse ventricular myocytesJ Gen Physiol113661678Year: 199910228181|
|37.||Fenske S,et al. HCN3 contributes to the ventricular action potential waveform in the murine heartCirc Res10910151023Year: 201121903939|
|38.||Kurrelmeyer KM,et al. Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarctionProc Natl Acad Sci USA9754565461Year: 200010779546|
|39.||Cheng H,Lederer WJ,Cannell MB. Calcium sparks: Elementary events underlying excitation-contraction coupling in heart muscleScience262740744Year: 19938235594|
|40.||Ljubojevic S,et al. In situ calibration of nucleoplasmic versus cytoplasmic Ca(2)+ concentration in adult cardiomyocytesBiophysical J10023562366Year: 2011|
Keywords: Cellular reprogramming, Cardiomyocyte, Cardiac fibroblast, Thymosin β4.
Previous Document: Restoration of grasp following paralysis through brain-controlled stimulation of muscles.
Next Document: Osteoprotection by semaphorin 3A.